BOSTON — Audax Private Equity (“Audax”) announced that it has partnered with management to recapitalize Belmont Instrument Corporation (“Belmont”), a leading provider of fluid warming infusion systems sold into acute care, military, and EMS settings. Headquartered in Billerica, MA, Belmont is a technology leader in rapid infusion systems used to treat critically injured patients experiencing material blood loss. Audax partnered with Belmont’s private owners in connection with the recapitalization.
*Geoffrey S. Rehnert, *Co-Chief Executive Officer, Audax Group, said, “Belmont is a best-in-class provider of life-sustaining fluid warming infusion systems. We are excited to partner with management to build on Belmont’s leading position and accelerate growth by continuing its investment in new product development, global marketing and salesforce expansion, and through acquisition of complementary patient warming and critical care medical technologies.”
Mirus Capital Advisors served as financial advisor, and Mintz Levin served as legal counsel to Belmont. Ropes & Gray served as legal counsel to Audax.
